INTRODUCTION
Many chemicals (5) , approved pharmaceutical drugs (6) , and even the natural food ingredient lactose (1) are reported to cause an increase in the incidence of interstitial cell adenoma in the testis of rats. These compounds come from several different chemical classes and have varied biologic actions. Some are mutagens; most are not.
Many of the compounds that are reported to cause interstitial cell adenomas are not regulated as carcinogens. This seeming contradiction is often rationalized on the basis of weight-of the-evidence arguments. Evidentiary factors that can be weighed include the results of genotoxicity studies, the tumor incidence in other organs or other species, the dose response, endocrine studies, and the level of statistical significance of differences between groups.
We suggest that another factor be considered: uncertainty of diagnosis. We show by conditional probability analysis why arbitrarily chosen diagnostic criteria that seem to be valid in the Fischer-344 (F-344) rat cause confusion, overdiagnosis, and uncertainty when used in Sprague-Dawley (SD) rats.
COMMONLY USED CRITERIA FOR THE DIAGNOSIS OF INTERSTITIAL CELL ADENOMA IN THE RAT
Size of lesion is the criterion most commonly used to differentiate interstitial cell hyperplasia from adenoma in the rat in toxicology studies. The National Toxicology Program (NTP) adopted the diameter of 1 normal seminiferous tubule as the upper limit of size of interstitial cell hyperplasia. Larger lesions are classified as adenoma (3, 4) . Compression of surrounding tubules, increased mitosis, cellular pleomorphism, and formation of vascular spaces are given as aids in the diagnosis, but size of lesion is the primary determinant.
European toxicologic pathologists have generally adopted the diameter of 3 normal seminiferous tubules as their cut-off point (8) . Thus, although the European criterion is not as strict as that used by the NTP, it also relies primarily on size of lesion to differentiate hyperplasia from adenoma. The NTP adopted size as a seemingly objective diagnostic criterion to standardize the diagnosis among the many studies, pathologists, and laboratories that conduct bioassays for the program. The NTP recognized that the chosen size was arbitrary.
The NTP uses F-344 rats. The same diagnostic criteria that the NTP recommends for interstitial cell proliferative lesions in F-344 rats have been applied to SD rats (9) . The implied assumption that criteria that appear to be valid in one strain can be used in another strain seems not to have been seriously questioned.
ERROR RATE AND PREVALENCE EFFECT ON TEST RELIABILITY
In F-344 rats, the prevalence (usually called incidence) of large, grossly visible interstitial cell masses interpreted to be adenomas is nearly 100~n in rats that live 2 yr or more (3) . In SD rats, the prevalence of such masses in aged males is in the range of 5-10% (7) . It is clear from these data that the prevalence of interstitial cell adenoma is much lower in SD rats than in F-344 rats. This change of prevalence between the different strains has a marked influence on the reliability of any scheme for the microscopic differentiation of interstitial cell hyperplasia from adenoma.
The diagnosis of neoplasia (e.g., adenoma) is binary. A lesion either is or is not labeled an adenoma.
However, the morphologic characteristics used to make the diagnosis occur as continuous variables.
A focus of interstitial cell proliferation can have any size above that of a normal collection of cells in the interstitium. The mitotic index can take any value from 0 to 100%. Vascularity, pleomorphism, and other recommended criteria are subjective and theoretically can be graded on a continuous spectrum. The transitions from normal to hyperplasia to neoplasia do not have distinct borders. Making a binary choice using continuous variables requires the selection of a cut-off point. That point will always be arbitrarily chosen. It will therefore have an error rate. For some distance around the cut-off point, some true positives will satisfy the criteria for negativity, and some true negatives will satisfy the criteria for positivity. It might seem possible to estimate the error rates, choose criteria that minimize total error, and proceed, accepting an established percentage of falsepositive and false-negative diagnoses. However, the reliability of a diagnostic test does not depend only on error rate. The prevalence of the condition in the population of interest has a major influence on test reliability. This influence of prevalence seems not to have been appreciated when criteria that seemed reliable in F-344 rats were adopted for use in SD rats.
PREDICTIVE VALUE OF A POSITIVE AS A MEASURE OF TEST PERFORMANCE
In toxicologic pathology, we do not start with a population of known prevalence and attempt to find the criteria that will match that prevalence. (Such an exercise would determine the rates of false positives and false negatives.) Instead, we start with a population of unknown prevalence and attempt to determine the prevalence by the application of diagnostic tests. When determining interstitial cell tumor prevalence, we are primarily interested in the accuracy of a positive diagnosis; that is, how likely is it that an animal that is given a positive diagnosis comes from the population of animals that actually have an adenoma. That probability is fundamentally different from the probability that an animal that actually has an adenoma will be given a positive diagnosis.
The probability of occurrence of one event (e.g., actual occurrence of an adenoma), given that another event has occurred (e.g.. diagnosis of adeno-ma), is called conditional probability and can be determined using Bayes' theorem (2) .l In medicine, Bayes' theorem is usually used to estimate the &dquo;predictive value&dquo; of a positive test result-that is, the probability that a positive test result &dquo;predicts&dquo; the presence of the disease. This probability is conceptually different from the probability that an animal with the disease will be diagnosed as positive. The latter parameter is termed sensitivity and is calculated as [ 1 -(% false negatives/ 100)].
The validity of the diagnostic criteria used to evaluate interstitial cell proliferations in rats has not been experimentally confirmed against any proven reference method, so the rates of false positives and false negatives that occur during the histologic diagnosis of interstitial cell adenoma cannot be determined with certainty. Therefore, the exact predictive value of a histologic diagnosis cannot be calculated. However, the problems associated with the use of arbitrary criteria in populations with different prevalences can be illustrated by using assumed values. For purposes of illustration, we will assume that the histologic diagnosis of interstitial cell adenoma of the testis in the rat has a falsepositive rate of 10% (10% of truly negative animals are diagnosed positive) and a false negative rate of 1 % ( 1 % of truly positive animals are diagnosed as negative). These are conservative assumptions given the strict nature of the diagnostic criterion used (i.e., comparison to the size of 1 normal seminiferous tubule). The principle remains the same if these assumptions are not exactly correct. Predictive value can be easily determined from a simple table if the rate of false positives, the rate of false negatives, and the prevalence are known. To construct the table, a hypothetical total population of 100 is distributed in the right-hand column according to the percentage of true positives and true negatives. Those Table II , when the prevalence drops to 10% (approximating the spontaneous incidence of interstitial cell adenoma in SD rats), overall accuracy remains high (90.9%), and negative diagnoses are highly accurate (99.9%), but only 52% of diagnosed positives are true positives. The remaining 48% of diagnosed positives are false-positive diagnostic errors.
As shown in

RELEVANCE OF PREDICTIVE VALUE ANALYSIS TO INTERSTITIAL CELL TUMORS IN SD RATS
The size criteria recommended by both the NTP and European groups are very strict and are prone to give false positives. There is no reason to believe that some foci of nonneoplastic interstitial cell hyperplasia cannot grow to a size larger than 1 or 3 seminiferous tubule diameters. As shown in Table   I , diagnostic criteria that are very strict, and therefore may yield false positives, work well in populations with a high prevalence. This is because those populations contain few individuals that are truly negative and are thus candidates for a false-positive diagnosis. If F-344 rats are used in studies, strict criteria appear to be more valid than lax criteria, because they more closely confirm the high prevalence seen by the reference method (in this case, gross enlargement at terminal necropsy). Indeed, if the pathologist evaluating tissues from F-344 rats simply omits examination of the testes, and automatically assigns the diagnosis of interstitial cell adenoma to all males, then both the predictive value of a positive diagnosis and the overall accuracy rate will be 95%. Under such conditions, it is virtually impossible to refute the validity of any arbitrary criterion for diagnosis if that criterion is strict enough to yield an incidence similar to that of the reference method.
The situation is very different when a population with a prevalence of 10%, like the SD rat, is studied.
Ninety percent of this population are true negatives and are thus candidates for a false-positive diagnosis. The relatively low false-positive rate (10%) will be applied to a large proportion of the population (90%), yielding a high ratio of false positives to true positives (9%/9.9%).
This illustration demonstrates that when the prevalence of interstitial cell tumors is high, the stricter the criteria, the more accurate will be the results for positive diagnoses. When the prevalence is low, the stricter the criteria, the more erroneous will be the results for positive diagnoses.
The example above uses a prevalence rate similar to the normal background prevalence of interstitial In the more likely situation, in which a test article causes nonneoplastic interstitial cell hyperplasia, the number of proliferative lesions that fulfill the size criterion for adenoma will increase. This will alter the error rate, increasing the rate of false-positive adenoma diagnoses and thereby reduce the predictive value of a positive. If the rate of false positives increases from 10 to 20%, other conditions remaining the same, the decrease in the predictive value of a positive diagnosis will be imperceptible if the true prevalence is 95%, but it will be large if the true prevalence is 10%. In the latter case, nearly twothirds of diagnosed positives will be false-positive error. Under such a condition, the comparison of &dquo;tumor&dquo; prevalence among groups in a study may yield an erroneous conclusion.
SUMMARY '
Arbitrary criteria can give unreliable diagnoses. Conditions that occupy the same marginal diagnostic space, such as interstitial cell hyperplasia and interstitial cell adenoma, sometimes will be mistaken for one another. When the true prevalence is low, the risk of false positives, as a percentage of all positives, is high. The preceding analysis predicts that, with currently recommended diagnostic criteria, any compound that causes nonneoplastic interstitial cell hyperplasia will be interpreted to cause interstitial cell neoplasia if SD rats are used and only micro- 2 If the rate of false positives rises from 10 to 20%, then the predictive value of a positive will fall from 99 to 98.9%, if the prevalence is 95% and false negatives remain at 1%. It will fall from 52 to 35.5% if the prevalence is 10%. Total accuracy will be 98 and 81.9%, respectively. The reader can easily confirm these calculations by modifying Tables I and II appropriately. scopic diagnoses are considered. Conversely, the analysis predicts that no compound that actually causes neoplasia in interstitial cells will be identified as an interstitial cell tumorigen if F-344 rats are used and only microscopic diagnoses are considered. These predictions are consistent with experience.
